Overview
Alzheimer's disease is a neurodegenerative disorder commonly associated with aging. It affects the brain's ability to function normally, leading to memory loss, cognitive decline, and changes in behavior. Alzheimer's is a severe condition that can affect an individual's quality of life and their ability to carry out daily activities. In the last decade, many neurological researchers have explored new therapeutic approaches to slow down the progression of Alzheimer's disease. These therapeutic approaches include developing new drugs, testing non-invasive treatments, and behavioral modification in patients with mild cognitive impairment. One of the most promising therapeutic approaches for Alzheimer's disease is using gene therapy. Gene therapy involves the use of a gene (ADAM10) that regulates the production of beta-amyloid peptides in the brain. Beta-amyloid is the primary cause of Alzheimer's disease as it accumulates and forms plaques in the brain, disrupting normal brain function. Gene therapy aims to reduce the production of beta-amyloid, slowing down the progression of the disease. Another therapeutic approach to Alzheimer's disease is developing new drugs. Biochemical research has identified several targets that can reduce the beta-amyloid peptide accumulation. The drugs developed target the enzymes that produce the beta-amyloid peptide. The therapeutic approach aims to reduce the accumulation of beta-amyloid, thereby slowing down the progression of the disease. Finally, non-invasive treatments like transcranial magnetic stimulation (TMS) have also shown promise in treating Alzheimer's disease. TMS uses a magnetic field to stimulate specific regions of the brain, promoting brain plasticity and cognitive function. Overall, ongoing neurological research aims to develop new therapeutic approaches that can improve the quality of life for individuals with Alzheimer's disease and their caregivers.